share_log

CORRESP: CORRESP

CORRESP: CORRESP

CORRESP:信函
美股SEC公告 ·  05/28 22:35

Moomoo AI 已提取核心訊息

Apollomics Inc., a biopharmaceutical company, has formally requested the U.S. Securities and Exchange Commission (SEC) to accelerate the effective date of its Registration Statement on Form F-3. The company seeks to have the registration become effective on May 29, 2024, at 4:00 p.m. Eastern Time. This request was made in accordance with Rule 461 of Regulation C under the Securities Act of 1933. Apollomics has indicated that the effective date may be adjusted if necessary, based on further communication with the SEC. The company's legal counsel, Ryan Coombs from O'Melveny & Myers LLP, is the primary contact for this matter, with Yoon-jee Kim available in his absence.
Apollomics Inc., a biopharmaceutical company, has formally requested the U.S. Securities and Exchange Commission (SEC) to accelerate the effective date of its Registration Statement on Form F-3. The company seeks to have the registration become effective on May 29, 2024, at 4:00 p.m. Eastern Time. This request was made in accordance with Rule 461 of Regulation C under the Securities Act of 1933. Apollomics has indicated that the effective date may be adjusted if necessary, based on further communication with the SEC. The company's legal counsel, Ryan Coombs from O'Melveny & Myers LLP, is the primary contact for this matter, with Yoon-jee Kim available in his absence.
生物製藥公司Apollomics Inc.正式請求美國證券交易委員會(SEC)加快其F-3表格註冊聲明的生效日期。該公司希望該註冊生效日期設定爲2024年5月29日,美國東部時間下午4:00。此請求是根據證券法規C下461號規則提出的。Apollomics表示,如果有必要,生效日期可能會根據與SEC的進一步溝通進行調整。該公司的法律顧問,O'Melveny & Myers LLP的Ryan Coombs是該事項的主要聯繫人,缺席時可聯繫Yoon-jee Kim。
生物製藥公司Apollomics Inc.正式請求美國證券交易委員會(SEC)加快其F-3表格註冊聲明的生效日期。該公司希望該註冊生效日期設定爲2024年5月29日,美國東部時間下午4:00。此請求是根據證券法規C下461號規則提出的。Apollomics表示,如果有必要,生效日期可能會根據與SEC的進一步溝通進行調整。該公司的法律顧問,O'Melveny & Myers LLP的Ryan Coombs是該事項的主要聯繫人,缺席時可聯繫Yoon-jee Kim。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息